FDA information regarding Biosimilars

Posted in Latest News on August 26, 2013.

The FDA has created a pathway for the approval of biosimilar products, but has not yet approved a biological product as biosimilar or interchangeable. There is no date-certain for when these products will be approved—some estimates are three to five years.
The Board of Pharmacy has established a link on its website to the FDA pathway for approval of biosimilar biological products.



More Latest News

Texas aids sheltering evacuees in accessing prescription medications
September 12, 2017

Consideration of the Texas model medication coverage for evacuees in shelters is under consideration in Florida Continue reading


Operating in Florida under Emergency Executive Orders
September 8, 2017

Find out how to volunteer and know the restrictions regarding advanced supplies of Schedule II controlled substances. Continue reading